Mapping the road to biologics in psoriasis and psoriatic arthritis: A nationwide drug utilization study
Abstract Background Limited research has been conducted on whether advances in novel biologics and biosimilars have improved the treatment journey preceding biologics. Objectives To map the overall treatment journey preceding the initiation of first biologic therapy in patients with psoriasis (PsO)...
Main Authors: | David Thein, Nana A. L. Rosenø, Mia‐Louise Nielsen, Lars Erik Kristensen, Julia‐Tatjana Maul, Jashin J. Wu, Simon Francis Thomsen, Jacob P. Thyssen, Alexander Egeberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | JEADV Clinical Practice |
Subjects: | |
Online Access: | https://doi.org/10.1002/jvc2.194 |
Similar Items
-
SYSTEM THERAPY OF PSORIASIS IN CHILDREN (PART I)
by: L. S. Namazova-Baranova, et al.
Published: (2017-10-01) -
Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study
by: Federica Ricceri, et al.
Published: (2022-05-01) -
Editorial: Therapeutic Advancements in Psoriasis and Psoriatic Arthritis
by: Saumya Panda
Published: (2022-03-01) -
Azathioprine and hydroxychloroquine overdose in Sjögren’s syndrome patient with hypocalcemia: a case report
by: Alireza Kooshki, et al.
Published: (2024-02-01) -
Introducing a simplified titration scheme for dimethylfumarate (DMF) in patients with moderate-to-severe psoriasis: a case series
by: Ralph von Kiedrowski, et al.
Published: (2022-05-01)